These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31005341)

  • 1. Bleeding risk assessment for stroke patients on antithrombotic therapy.
    Castilla-Guerra L; Fernández-Moreno MDC; de la Vega-Sánchez JM; Leon Jimenez D
    Clin Investig Arterioscler; 2019; 31(6):282-288. PubMed ID: 31005341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis.
    Zhang Q; Wang C; Zheng M; Li Y; Li J; Zhang L; Shang X; Yan C
    Cerebrovasc Dis; 2015; 39(1):13-22. PubMed ID: 25547900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis.
    Lee M; Saver JL; Hong KS; Rao NM; Wu YL; Ovbiagele B
    Ann Intern Med; 2013 Oct; 159(7):463-70. PubMed ID: 24081287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External Validation of Risk Scores for Major Bleeding in a Population-Based Cohort of Transient Ischemic Attack and Ischemic Stroke Patients.
    Hilkens NA; Li L; Rothwell PM; Algra A; Greving JP
    Stroke; 2018 Mar; 49(3):601-606. PubMed ID: 29459399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction models for intracranial hemorrhage or major bleeding in patients on antiplatelet therapy: a systematic review and external validation study.
    Hilkens NA; Algra A; Greving JP
    J Thromb Haemost; 2016 Jan; 14(1):167-74. PubMed ID: 26563743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review and management of side effects associated with antiplatelet therapy for prevention of recurrent cerebrovascular events.
    Guthrie R
    Adv Ther; 2011 Jun; 28(6):473-82. PubMed ID: 21547541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triflusal and aspirin in the secondary prevention of atherothrombotic ischemic stroke: a very long-term follow-up.
    Alvarez-Sabín J; Quintana M; Santamarina E; Maisterra O
    Cerebrovasc Dis; 2014; 37(3):181-7. PubMed ID: 24503927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials.
    Kheiri B; Osman M; Abdalla A; Haykal T; Swaid B; Ahmed S; Chahine A; Hassan M; Bachuwa G; Al Qasmi M; Bhatt DL
    J Thromb Thrombolysis; 2019 Feb; 47(2):233-247. PubMed ID: 30511260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
    Algra A; de Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
    Cochrane Database Syst Rev; 2001; (4):CD001342. PubMed ID: 11687110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Follow-Up After Closure of Patent Foramen Ovale in Patients With Cryptogenic Embolism.
    Wintzer-Wehekind J; Alperi A; Houde C; Côté JM; Asmarats L; Côté M; Rodés-Cabau J
    J Am Coll Cardiol; 2019 Jan; 73(3):278-287. PubMed ID: 30678757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin.
    Ye S; Cheng B; Lip GY; Buchsbaum R; Sacco RL; Levin B; Di Tullio MR; Qian M; Mann DL; Pullicino PM; Freudenberger RS; Teerlink JR; Mohr JP; Graham S; Labovitz AJ; Estol CJ; Lok DJ; Ponikowski P; Anker SD; Thompson JL; Homma S;
    Am J Cardiol; 2015 Sep; 116(6):904-12. PubMed ID: 26189039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation.
    Golive A; May HT; Bair TL; Jacobs V; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
    Am J Cardiol; 2017 Jul; 120(1):75-82. PubMed ID: 28483209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack.
    Saxena R; Koudstaal P
    Cochrane Database Syst Rev; 2004 Oct; (4):CD000187. PubMed ID: 15494992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a systematic review and meta-analysis.
    Ding L; Peng B
    Eur J Neurol; 2018 Oct; 25(10):1276-1284. PubMed ID: 29855121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteric-coated aspirin versus other antiplatelet drugs in acute non-cardioembolic ischemic stroke: post-marketing study in Japan.
    Takahashi S; Mizuno O; Sakaguchi T; Yamada T; Inuyama L
    Adv Ther; 2014 Jan; 31(1):118-29. PubMed ID: 24385407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
    Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS
    Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The association of lipid profile and bleeding in patients with minor stroke or transient ischemic attack on antiplatelet therapy: subgroup analysis of CHANCE].
    Li JJ; Gu HQ; Peng YJ; Zhao XQ; Wang YL; Meng X; Liu LP; Wang YJ
    Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):723-730. PubMed ID: 30293332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.